Navigation Links
Saudi Arabian camels carry MERS virus
Date:2/25/2014

mples to test the hypothesis.

New Mobile Lab, Saudi Collaboration

Alongside its insights into MERS-CoV, the study also cemented collaborations and validated systems that will carry forward into future studies of MERS-CoV and other infectious disease threats.

"The study is the first collaboration between the Center for Infection and Immunity and King Saud University, as well as the first to use the Center's new mobile field laboratory, that is designed to enable surveillance, discovery and service missions in support of international organizations like the World Health Organization," says senior author W. Ian Lipkin, MD, director of the Center for Infection and Immunity and the John Snow Professor of Epidemiology at the Mailman School. "We look forward to continued work toward to ultimate goal of eliminating the threat of MERS and other infectious agents to human health."


'/>"/>
Contact: Timothy S. Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Dissertation Help Launched in Saudi Arabia, UAE and other Middle Eastern Countries
2. Pacific Prime Clients with Aetna Gain New Medical Insurance Options in Saudi Arabia
3. Saudi Arabia Pharmaceutical Market Sales at US$7B by 2018 Forecasts a New Research Available at MarketReportsOnline.com
4. Elk Consulting poised to serve scholars in Saudi Arabia
5. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
6. People Carrying Guns May Appear Bigger Than They Are
7. Some Schools Dont Let Kids Carry Asthma Inhalers
8. African Chimps Carry Drug-Resistant, Human-Linked Staph
9. Herceptin May Carry Higher Heart Risks for Women Than Thought
10. Stop-Smoking Drug Chantix May Carry Heart Risks, FDA Warns
11. Deer Ticks Carry Yet Another Bacterial Threat
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Saudi Arabian camels carry MERS virus
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
(Date:7/2/2015)... , ... July 02, 2015 , ... With summer in full swing, Americans are flocking ... one of the top spots for fishing in the world, and it’s easy to understand ... Ontario, Canada has great fish. , Recreational fishing is a huge industry, and Americans ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, ... designed for men. , For style that’s quick on its feet, men will ... is great news for men everywhere because a simple change in socks can dramatically ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4
... use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) ... men with prostate cancer, say researchers at Vanderbilt University. ... Health Study included 1,277 participants referred to a urologist ... of the men reported taking an NSAID, mostly aspirin ...
... long-term, randomized clinical trial that included 14,641 physicians who were ... given 400 IU of vitamin E every other day or ... its placebo. , Researchers followed these patients for up ... rates of completion of annual questionnaires, and the confirmation of ...
... characterized as being in "denial" not recognizing the ... to be a form of deception, emerging research suggests ... dysfunction similar to that observed in other neuropsychiatric illnesses. ... relevant research during a symposium on "Impaired Insight into ...
... DPL™ Therapy System for temporary relief of pain. , ... ... announced today that the U.S. Food and Drug Administration (FDA) cleared ... of muscle spasms, temporary relief of minor muscle and joint aches, ...
... A protein known to inhibit the growth of ovarian ... themselves until they die, researchers at The University of Texas ... issue of Cancer Research . , The research team ... is an independent indicator of a woman,s prospects for surviving ...
... Finding may explain why treatment and outcomes are different among ... lung tumors tend to have a different genetic makeup in ... treatment and outcomes are different among races, a new study ... to carry more copies of the epidermal growth factor receptor ...
Cached Medicine News:Health News:Men who take aspirin have significantly lower PSA levels 2Health News:Men who take aspirin have significantly lower PSA levels 3Health News:No protective effect on cancer from long-term vitamin E or vitamin C supplementation 2Health News:'Insight' deficit may explain denial in drug addiction 2Health News:'Insight' deficit may explain denial in drug addiction 3Health News:FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use 2Health News:Protein compels ovarian cancer cells to cannibalize themselves 2Health News:Lung Cancer Genetics Different in Black Patients: Study 2
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
(Date:7/2/2015)... NEW YORK , July 2, 2015 /PRNewswire/ ... of a conspicuously high-growth market segment in hematology ... research publisher said that Roche,s recent unveiling of its ... into the cobas m 511 hematology ... not only capture growth enjoyed by current leader ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... percent of patients treated with VELCADE, cyclophosphamide,and ... Greece, June 28, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, ... results,from clinical trials of VELCADE based therapies ... (CR) rates in previously,treated multiple myeloma (MM) ...
... 29, 2007 /PRNewswire/ --,The European Myeloma Platform (EMP) ... (lenalidomide) plus the,steroid dexamethasone shows median survival of ... from two large randomized,controlled Phase III trials that ... sites worldwide. These updated results,were presented at the ...
Cached Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2
... Powerful and Flexible Impact And Impact2 Pipettors ... volume ranges, our single channel Impact and ... of any application. Engineered with the same ... multichannel line, these pipettors are equally easy ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra ... strain, Stress-free tip ejection with long, ... easy volume identification, Accepts universal tips ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Inquire...
Medicine Products: